Not all eicosanoids are bad
- 1 December 2006
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 27 (12) , 609-611
- https://doi.org/10.1016/j.tips.2006.10.001
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Resolution of inflammation: the beginning programs the endNature Immunology, 2005
- 15-epi-lipoxin A4–mediated Induction of Nitric Oxide Explains How Aspirin Inhibits Acute InflammationThe Journal of Experimental Medicine, 2004
- Exogenous Pathogen and Plant 15-Lipoxygenase Initiate Endogenous Lipoxin A4 BiosynthesisThe Journal of Experimental Medicine, 2004
- Does the failure to acquire helminthic parasites predispose to Crohn's disease?The FASEB Journal, 2000
- Prostaglandin D 2 as a Mediator of Allergic AsthmaScience, 2000
- Lipoxin A4: A New Class of Ligand for the Ah ReceptorBiochemistry, 1999
- Eicosanoids and inflammationThe Journal of Pathology, 1988
- From studies of biochemical mechanism to novel biological mediators: Prostaglandin endoperoxides, thromboxanes, and leukotriencesBioscience Reports, 1983
- 2,3,7,8-Tetrachlorodibenzo-p-Dioxin and Related Halogenated Aromatic Hydrocarbons: Examination of the Mechanism of ToxicityAnnual Review of Pharmacology and Toxicology, 1982
- Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesNature, 1980